Modulation of gut microbiota in targeted cancer therapy: insights on the EGFR/VEGF/KRAS pathways
The rise in the incidence of cancer globally has led to a heightened interest in targeted therapies as a form of anticancer treatment. Key oncogenic targets, including epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF), and kirsten rat sarcoma viral oncogene homologue...
Saved in:
Main Authors: | Li Gong, Shixue Yang, Junli Huang, Yongsheng Li |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2024-12-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | https://www.cancerbiomed.org/content/21/12/1141 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Harnessing gut microbiota for longevity: Insights into mechanisms and genetic manipulation
by: Peng Shi, et al.
Published: (2024-12-01) -
In vitro modeling of feline gut fermentation: a comprehensive analysis of fecal microbiota and metabolic activity
by: Qianle Ren, et al.
Published: (2025-01-01) -
Gut Microbiota Secondary Metabolites: Key Roles in GI Tract Cancers and Infectious Diseases
by: Eman K. E. Anwer, et al.
Published: (2025-01-01) -
A Case of Non-Small Cell Lung Cancer with Mutually Exclusive <i>EGFR</i> and <i>KRAS</i> Mutations
by: Abhimanyu Tushir, et al.
Published: (2025-01-01) -
Fecal microbiota transplantation alleviates radiation enteritis by modulating gut microbiota and metabolite profiles
by: Qin Ding, et al.
Published: (2025-02-01)